SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-15-410047
Filing Date
2015-12-22
Accepted
2015-12-22 10:03:59
Documents
4

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE TO d108421dsctota.htm SC TO-T/A 25969
2 EXHIBIT (A)(1)(K) d108421dex99a1k.htm EX-99.(A)(1)(K) 8667
3 GRAPHIC g108421g52b23.jpg GRAPHIC 33180
4 GRAPHIC g108421g87l33.jpg GRAPHIC 32519
  Complete submission text file 0001193125-15-410047.txt   126958
Mailing Address 33 LOCKE DRIVE MARLBOROUGH MA 01752
Business Address 33 LOCKE DRIVE MARLBOROUGH MA 01752 508-756-1212
Ocata Therapeutics, Inc. (Subject) CIK: 0001140098 (see all company filings)

IRS No.: 870656515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-79462 | Film No.: 151301064
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2-5-1, NIHONBASHI-HONCHO CHUO-KU TOKYO M0 103-8411
Business Address 2-5-1, NIHONBASHI-HONCHO CHUO-KU TOKYO M0 103-8411 81-3-3244-3231
Astellas Pharma Inc. (Filed by) CIK: 0001376684 (see all company filings)

IRS No.: 132971791
Type: SC TO-T/A